Aperio Group’s Rockwell Medical RMTI Stock Holding History

Aperio Group’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7	Closed	-$2K	–	2668
2019 Q2	$2K	Buy	+7	New	+$3.56K	﹤0.01%	2939

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Aperio Group's RMTI Position: Q3 2019 in Review

Aperio Group sold out of Rockwell Medical (RMTI) in Q3 2019, closing a stake of 7 shares — an estimated $2K sold.

Aperio Group first reported a position in RMTI in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 90 funds tracked by Wall St. Rank hold RMTI as of Q3 2019.

Aperio Group reported no remaining Rockwell Medical position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 7 Rockwell Medical shares in Q3 2019, an estimated $2K.
Aperio Group first reported a position in Rockwell Medical in Q2 2019 and held it in 1 quarter.
Aperio Group's Rockwell Medical position peaked at $2K in Q2 2019.
90 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.